SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
BDSX

Biodesix Inc (BDSX)

NASDAQ: BDSX · USD
Healthcare · Diagnostics & Research
$7.56-$0.74 (-8.92%)
 
Market cap
$83.8M
Insider Score
Analyst consensus
Market Cap$83.83M+16.1%
Revenue (ttm)$105.21M
Net Income-$27.08M
EPS-$2.69
Shares Out11.09M
PE Ration/a
Forward PE-34.36
Dividendn/a
Ex-Dividend Daten/a
Volume205,366
Open$8.17
Previous Close$8.30
Day's Range$7.50 - $8.45
52-Week Range$5.26 - $31.97
Beta0.63
AnalystsStrong Buy
Price Target$32.17(+325.49%)
Earnings DateNov 5, 2026
-8.92% (1D)
No price history available.

About BDSX

Biodesix, Inc. operates as a diagnostic solutions company. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests markets as Nodify Lung Nodule Risk Assessment testing to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR, GeneStrat NGS, and VeriStrat tests markets as part of IQLung testing strategy, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to guide treatment decisions. In addition, the company provides diagnostic solutions, including translational research, initial biomarker discovery, assay design, development and validation, testing of clinical trial samples, regulatory, reimbursement, commercialization, and logistical support services for biopharmaceutical, life sciences, and diagnostic companies. Further, it operates laboratories. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado.

Address
919 West Dillon Road, Louisville, CO, 80027, United States
Market Cap
84 million
Employees
334
Industrial Classification
Diagnostics & Research

What Are Insiders Doing?

Open-market buy / sell balanceNet Buying
Sold
$100.24K
Bought
$2.27M

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Analyst consensus

Moderate Buy
3 Buy0 Hold0 SellAvg target $33.50 (+343.1%)

3 firms rating BDSX in the last 3 months, one vote each. Issuer-paid research is not counted.

1 Day
-8.92%
5 Days
-23.48%
1 Month
-68.42%
6 Months
-49.36%
1 Year
+16.13%

$BDSX stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in BDSX holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by BDSX's directors and management

Net Shares Purchased by Insiders−100k−50k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

BDSX Estimated quarterly lobbying spending

Source: U.S. Senate LDA

BDSX Revenue by Segment

$24.04MTotal
Diagnostic Tests$23.05M95.90%
Development Services$986.00K4.10%

As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New BDSX patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to BDSX from public contracts

Source: USAspending.gov

Bull Case vs Bear Case

AI-generated from BDSX’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
48% of score
0
Analyst Ratings
32% of score
99
News & Sentiment
20% of score
35

News check: Q3 earnings miss and guidance cut drive bearish tone; insider buying and conference presentation provide modest support but cannot offset negative fundamentals.

Recent Insider Activity

Buys
5
Sells
10
Buy Value
$2.27M
Distinct Buyers
1

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

GNMXCorgi ETF Trust I - Corgi Genomics & Precision Medicine ETF0.24%
BUSMEA Series Trust - EA Bridgeway Ultra-Small Company Market ETF0.11%

Weight is the stock’s share of each fund’s holdings.